Здоровье

Promising discovery for Alzheimer’s: First symptoms appear in eyes

US scientists have published the results of a new study on Alzheimer’s disease. Accordingly, the first symptoms of the disease appear in the eyes. The study is also shown as a promising development in the early diagnosis of the disease.

Recent research has uncovered a truth about early detection of Alzheimer’s. US scientists collected retinal and brain tissue samples from 86 different people over 14 years.
According to CNN International’s report, this is one of the largest studies ever done.
These samples from healthy people were compared with those with both initial and advanced Alzheimer’s disease.
The findings proved that the first signs of the disease were seen in the eyes.
Studies have revealed that Alzheimer’s patients begin to have inflammation in their eyes at an early age and decrease the number of certain cells in the brain. In this way, early diagnosis of the disease will be possible with new eye tests.
Recently, studies on Alzheimer’s disease have been accelerated. Finally, the US Food and Drug Administration approved a new drug that appears to slow the disease.
The drug, approved for use, is the first of its kind to show that it can slow the decline in memory and thinking.
However, experts emphasize that the drug is not curative, it will only measurably slow the progression of the disease.

This news has been translated by google translate.

Source Link: NTV/BRT/CNN

ACM Cyprus

ACM Cyprus

Esta Construction

Pools Plus Cyprus

Artificial intelligence has reinterpreted this news for you.

According to a new study by US scientists, the first symptoms of Alzheimer’s disease appear in the eyes. The study collected retinal and brain tissue samples from 86 different people over a period of 14 years, and found that inflammation in the eyes and decreased cell count in the brain are early signs of the disease. The study is being hailed as a promising development in the early diagnosis of Alzheimer’s. Recently, the US Food and Drug Administration approved a new drug that can slow the decline of memory and thinking in Alzheimer’s patients, though experts emphasize that the drug is not curative.

Related Articles

Добавить комментарий

Ваш адрес email не будет опубликован. Обязательные поля помечены *

Back to top button